Abrocitinib May Relieve Symptoms of Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Abrocitinib (Cibinqo, Pfizer) improves the symptoms of prurigo nodularis and chronic pruritus of unknown origin, according to a new study in JAMA Dermatology. The 12-week study involved 20 patients, half of whom had prurigo nodularis and half of whom had chronic pruritus of unknown origin. They were all given a 200-milligram pill of abrocitinib once a day for 12 […]